Table 4.
Variable | Reconstructed with Prior Augmentation (n = 16) | Reconstructed Non-augmented (n = 222) | P |
---|---|---|---|
Bilateral reconstruction* | |||
Yes | 12 (75.0) | 177 (79.7) | 0.60 |
Alloplastic reconstruction* | |||
Yes | 16 (100.0) | 197 (88.7) | 0.15 |
Timing of reconstruction* | |||
Immediate | 16 (100.0) | 201 (90.5) | |
Delayed | 0 (0.0) | 21 (9.5) | 0.37 |
Type of implant reconstruction* | |||
Two-stage reconstruction | 12 (75.0) | 141 (63.5) | |
Direct to implant, saline | 0 (0.0) | 14 (6.3) | |
Direct to implant, silicone | 4 (25.0) | 44 (19.8) | 0.42 |
Final implant type* | |||
Saline | 4 (25.0) | 58 (32.0) | |
Silicone | 11 (68.8) | 96 (53.0 | |
Tissue expanders | 1 (6.3) | 27 (14.9) | 0.43 |
ADM use* | |||
Yes | 9 (56.3) | 116 (55.8) | 1.00 |
Implant removal* | |||
Yes | 2 (12.5) | 38 (20.0) | 0.74 |
Revision* | |||
Yes | 7 (43.8) | 100 (45.0) | 0.80 |
Denotes outcomes reported as total number (percentage).
ADM, acellular dermal matrix.